Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes

• Published in: Archives of toxicology 2023-06, Vol.97 (6), p.1649-1658
• Main Authors: Ticiani, Elvis, Pu, Yong, White, Madison, Adomshick, Victoria, Veiga-Lopez, Almudena
• Format: Article
• Language: English
• Subjects: 3T3-L1 Cells; Agonists; Animals; Antifouling coatings; Antifouling substances; Archives & records; Biocides; Biomedical and Life Sciences; Biomedicine; Body fat; Cell Differentiation; Chemicals; Dexamethasone; Dibutyltin; Differentiation; Environmental Health; Gene expression; Glucocorticoids; Industrial applications; Lipids; Metabolism; Mice; Mixtures; Molecular Toxicology; Monobutyltin; Occupational Medicine/Industrial Medicine; Organotin; Peroxisome proliferator-activated receptors; Pharmacology/Toxicology; PPAR gamma - metabolism; Preadipocytes; Receptors; Rosiglitazone; Sediments; Stannic chloride; Tin; Toxicology; Trialkyltin Compounds - toxicity; Tributyltin; Triphenyltin
• ISSN: 0340-5761; 1432-0738
• DOI: 10.1007/s00204-023-03512-5

Organotin chemicals (butyltins and phenyltins) are the most widely used organometallic chemicals worldwide and are used in industrial applications, such as biocides and anti-fouling paints. Tributyltin (TBT) and more recently, dibutyltin (DBT) and triphenyltin (TPT) have been reported to stimulate adipogenic differentiation. Although these chemicals co-exist in the environment, their effect in combination remains unknown. We first investigated the adipogenic effect of eight organotin chemicals (monobutyltin (MBT), DBT, TBT, tetrabutyltin (TeBT), monophenyltin (MPT), diphenyltin (DPT), TPT, and tin chloride (SnCl 4 )) in the 3T3-L1 preadipocyte cell line in single exposures at two doses (10 and 50 ng/ml). Only three out of the eight organotins induced adipogenic differentiation with TBT eliciting the strongest adipogenic differentiation (in a dose-dependent manner) followed by TPT and DBT, as demonstrated by lipid accumulation and gene expression. We then hypothesized that, in combination (TBT, DBT, and TPT), adipogenic effects will be exacerbated compared to single exposures. However, at the higher dose (50 ng/ml), TBT-induced differentiation was reduced by TPT and DBT when in dual or triple combination. We tested whether TPT or DBT would interfere with adipogenic differentiation stimulated by a peroxisome proliferator-activated receptor (PPARγ) agonist (rosiglitazone) or a glucocorticoid receptor agonist (dexamethasone). Both DBT50 and TPT50 reduced rosiglitazone-, but not dexamethasone-stimulated adipogenic differentiation. In conclusion, DBT and TPT interfere with TBT’s adipogenic differentiation possibly via PPARγ signaling. These findings highlight the antagonistic effects among organotins and the need to understand the effects and mechanism of action of complex organotin mixtures on adipogenic outcomes.